Overview
A. Non-small cell lung cancer
1. Evaluation of serum and tissue molecular biologic markers of recurrence in patients with a localize non-small cell lung cancer.
2. Molecular biologic staging of lymph nodes in patients with non-small cell lung cancer.
3. The evaluation of the clonality of metastatic tumors in patients with non-small cell lung cancer.
B. Clinical research activities
1. Creation of a prospective database for the Duke Thoracic Oncology Program.
2. A cost and satisfaction evaluation of thoracoscopy and open thoracotomy in patients.
3. Development of risk associated models of morbidity in patients undergoing general thoracic surgery procedures: The VA Cooperative Surgical Risk Study
4. A member of the Duke Gastrointestinal Malignancy Research Committee, developing esophageal cancer treatment protocols and outcome studies.
1. Evaluation of serum and tissue molecular biologic markers of recurrence in patients with a localize non-small cell lung cancer.
2. Molecular biologic staging of lymph nodes in patients with non-small cell lung cancer.
3. The evaluation of the clonality of metastatic tumors in patients with non-small cell lung cancer.
B. Clinical research activities
1. Creation of a prospective database for the Duke Thoracic Oncology Program.
2. A cost and satisfaction evaluation of thoracoscopy and open thoracotomy in patients.
3. Development of risk associated models of morbidity in patients undergoing general thoracic surgery procedures: The VA Cooperative Surgical Risk Study
4. A member of the Duke Gastrointestinal Malignancy Research Committee, developing esophageal cancer treatment protocols and outcome studies.
Current Appointments & Affiliations
George Barth Geller Distinguished Professor for Research in Cancer
·
2022 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Professor of Surgery
·
2003 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Professor in Pathology
·
2018 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
1987 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Going to MARS may shorten our patient's survival.
Journal Article J Thorac Cardiovasc Surg · June 2025 Full text Link to item CiteThe influence of the American Association for Thoracic Surgery on clinical trial development by cardiothoracic surgeons.
Journal Article J Thorac Cardiovasc Surg · May 2025 OBJECTIVE: Clinical trials play a critical role in the rapidly evolving field of cardiothoracic surgery and the American Association for Thoracic Surgery Clinical Trials Methods Course has provided a biannual symposium led by preeminent surgeons with vast ... Full text Link to item CiteInitial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacities.
Journal Article J Thorac Cardiovasc Surg · April 2025 OBJECTIVE: Presentation with multiple ground-glass opacities (GGOs) is an increasingly common occurrence, and the optimal management of these lesions is unclear. Active surveillance has been increasingly adopted as a management strategy for other low-grade ... Full text Link to item CiteRecent Grants
AstraZeneca AB / A multicentre, Phase II, single-arm, interventional study of neoadjuvant durvalumab and platinum-based chemotherapy (CT), followed by either surgery and adjuvant durvalumab or chemoradiotherapy (CRT) and consolidation durvalumab
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca AB · 2025 - 2029Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2029Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029View All Grants
Education, Training & Certifications
University of Virginia ·
1984
M.D.